Rate-controlled rectal drug delivery in man with a hydrogel preparation

L.G.J. de Leede, A.G. de Boer, E. Pörtzgen, J. Feijen, D.D. Breimer

Research output: Contribution to journalArticleAcademic

17 Citations (Scopus)
93 Downloads (Pure)

Abstract

Cylindrical hydrogels of hydroxyethyl methacrylate (HEMA) and ethylene glycol dimethacrylate (EGDMA) as crosslinking agent were prepared by radical polymerization at 70°C. After washing they were soaked in an aqueous drug solution of antipyrine or theophylline. The in vitro drug release experiments were performed in 100 ml isotonic glucose at 37°C. Rectal administration of a hydrogel preparation containing antipyrine was performed in two subjects for 72 h. With a theophylline-containing hydrogel preparation rectal drug administration was performed in six volunteers for 24 h. Plasma and saliva samples were taken regularly and the in vivo drug release was determined by means of a deconuolution procedure. In vitro 1.12g antipyrine had been released according to a matrix-type profile for 72 h, whereas it was calculated that this was 1.13 and 1.09 g in vivo in the two subjects. The release profile in vivo was very similar to that in vitro. The theophylline hydrogel preparation released in vitro a total of 288 ± 6 mg of drug in 24 h and in vivo this amount was calculated to be 288 ± 11 mg (mean ± s.d.). Near-constant plasma theophylline concentrations were obtained after administering the hydrogel preparation. In all six subjects the cumulative drug profile was in almost perfect agreement with that observed in vitro. Hydrogels offer interesting perspectives as rate-controlled rectal drug delivery systems because of the predictable release profile in vivo on the basis of observations in a simple in vitro model.
Original languageEnglish
Pages (from-to)17-24
JournalJournal of controlled release
Volume4
Issue number1
DOIs
Publication statusPublished - 1986

Fingerprint

Hydrogel
Theophylline
Antipyrine
Pharmaceutical Preparations
Rectal Administration
Hydrogels
Drug Delivery Systems
Saliva
Polymerization
In Vitro Techniques
Volunteers
Glucose

Cite this

de Leede, L.G.J. ; de Boer, A.G. ; Pörtzgen, E. ; Feijen, J. ; Breimer, D.D. / Rate-controlled rectal drug delivery in man with a hydrogel preparation. In: Journal of controlled release. 1986 ; Vol. 4, No. 1. pp. 17-24.
@article{16a5530e2598452ea473a24a4804b640,
title = "Rate-controlled rectal drug delivery in man with a hydrogel preparation",
abstract = "Cylindrical hydrogels of hydroxyethyl methacrylate (HEMA) and ethylene glycol dimethacrylate (EGDMA) as crosslinking agent were prepared by radical polymerization at 70°C. After washing they were soaked in an aqueous drug solution of antipyrine or theophylline. The in vitro drug release experiments were performed in 100 ml isotonic glucose at 37°C. Rectal administration of a hydrogel preparation containing antipyrine was performed in two subjects for 72 h. With a theophylline-containing hydrogel preparation rectal drug administration was performed in six volunteers for 24 h. Plasma and saliva samples were taken regularly and the in vivo drug release was determined by means of a deconuolution procedure. In vitro 1.12g antipyrine had been released according to a matrix-type profile for 72 h, whereas it was calculated that this was 1.13 and 1.09 g in vivo in the two subjects. The release profile in vivo was very similar to that in vitro. The theophylline hydrogel preparation released in vitro a total of 288 ± 6 mg of drug in 24 h and in vivo this amount was calculated to be 288 ± 11 mg (mean ± s.d.). Near-constant plasma theophylline concentrations were obtained after administering the hydrogel preparation. In all six subjects the cumulative drug profile was in almost perfect agreement with that observed in vitro. Hydrogels offer interesting perspectives as rate-controlled rectal drug delivery systems because of the predictable release profile in vivo on the basis of observations in a simple in vitro model.",
author = "{de Leede}, L.G.J. and {de Boer}, A.G. and E. P{\"o}rtzgen and J. Feijen and D.D. Breimer",
year = "1986",
doi = "10.1016/0168-3659(86)90029-5",
language = "English",
volume = "4",
pages = "17--24",
journal = "Journal of controlled release",
issn = "0168-3659",
publisher = "Elsevier",
number = "1",

}

Rate-controlled rectal drug delivery in man with a hydrogel preparation. / de Leede, L.G.J.; de Boer, A.G.; Pörtzgen, E.; Feijen, J.; Breimer, D.D.

In: Journal of controlled release, Vol. 4, No. 1, 1986, p. 17-24.

Research output: Contribution to journalArticleAcademic

TY - JOUR

T1 - Rate-controlled rectal drug delivery in man with a hydrogel preparation

AU - de Leede, L.G.J.

AU - de Boer, A.G.

AU - Pörtzgen, E.

AU - Feijen, J.

AU - Breimer, D.D.

PY - 1986

Y1 - 1986

N2 - Cylindrical hydrogels of hydroxyethyl methacrylate (HEMA) and ethylene glycol dimethacrylate (EGDMA) as crosslinking agent were prepared by radical polymerization at 70°C. After washing they were soaked in an aqueous drug solution of antipyrine or theophylline. The in vitro drug release experiments were performed in 100 ml isotonic glucose at 37°C. Rectal administration of a hydrogel preparation containing antipyrine was performed in two subjects for 72 h. With a theophylline-containing hydrogel preparation rectal drug administration was performed in six volunteers for 24 h. Plasma and saliva samples were taken regularly and the in vivo drug release was determined by means of a deconuolution procedure. In vitro 1.12g antipyrine had been released according to a matrix-type profile for 72 h, whereas it was calculated that this was 1.13 and 1.09 g in vivo in the two subjects. The release profile in vivo was very similar to that in vitro. The theophylline hydrogel preparation released in vitro a total of 288 ± 6 mg of drug in 24 h and in vivo this amount was calculated to be 288 ± 11 mg (mean ± s.d.). Near-constant plasma theophylline concentrations were obtained after administering the hydrogel preparation. In all six subjects the cumulative drug profile was in almost perfect agreement with that observed in vitro. Hydrogels offer interesting perspectives as rate-controlled rectal drug delivery systems because of the predictable release profile in vivo on the basis of observations in a simple in vitro model.

AB - Cylindrical hydrogels of hydroxyethyl methacrylate (HEMA) and ethylene glycol dimethacrylate (EGDMA) as crosslinking agent were prepared by radical polymerization at 70°C. After washing they were soaked in an aqueous drug solution of antipyrine or theophylline. The in vitro drug release experiments were performed in 100 ml isotonic glucose at 37°C. Rectal administration of a hydrogel preparation containing antipyrine was performed in two subjects for 72 h. With a theophylline-containing hydrogel preparation rectal drug administration was performed in six volunteers for 24 h. Plasma and saliva samples were taken regularly and the in vivo drug release was determined by means of a deconuolution procedure. In vitro 1.12g antipyrine had been released according to a matrix-type profile for 72 h, whereas it was calculated that this was 1.13 and 1.09 g in vivo in the two subjects. The release profile in vivo was very similar to that in vitro. The theophylline hydrogel preparation released in vitro a total of 288 ± 6 mg of drug in 24 h and in vivo this amount was calculated to be 288 ± 11 mg (mean ± s.d.). Near-constant plasma theophylline concentrations were obtained after administering the hydrogel preparation. In all six subjects the cumulative drug profile was in almost perfect agreement with that observed in vitro. Hydrogels offer interesting perspectives as rate-controlled rectal drug delivery systems because of the predictable release profile in vivo on the basis of observations in a simple in vitro model.

U2 - 10.1016/0168-3659(86)90029-5

DO - 10.1016/0168-3659(86)90029-5

M3 - Article

VL - 4

SP - 17

EP - 24

JO - Journal of controlled release

JF - Journal of controlled release

SN - 0168-3659

IS - 1

ER -